Clinical Trials Directory

Trials / Completed

CompletedNCT05721066

Hemostatic Profile of Post COVID-19/Long COVID-19 Patients

Status
Completed
Phase
Study type
Observational
Enrollment
102 (actual)
Sponsor
IRCCS Policlinico S. Donato · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The present study aims at assessing long-term hemostatic profile of patients recovered from COVID-19 acute infection that remain asymptomatic (POST-COVID) versus patients with residual symptoms (LONG-COVID) through the employment of a commercially available new generation point-of-care viscoelastic device. The primary endpoint is based upon the hypothesis that patients with residual symptoms maintain an abnormal coagulation profile even after recovery from COVID-19.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTClotPro assessmentPoint-of-care viscoelastic assessment of the coagulation profile (extrinsic pathway, intrinsic pathway, fibrinogen contribution, tPA stimulated fibrinolysis)
DIAGNOSTIC_TESTLaboratory analysisBlood count and standard coagulation tests (INR, aPTT, fibrinogen, D-dimers, antithrombin)
OTHERInterviewQuestionnaire from ISS (Istituto Superiore Sanità, the National Health Institute) about the health conditions before the acute COVID-19 infection, the disease (and the hospitalization) details and the eventual health disturbances experienced after the recovery from COVID-19 infection.

Timeline

Start date
2022-04-12
Primary completion
2022-11-15
Completion
2022-11-15
First posted
2023-02-09
Last updated
2023-02-16

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05721066. Inclusion in this directory is not an endorsement.